Tidal Investments’s Royalty Pharma RPRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.12M | Sell |
31,117
-344
| -1% | -$12.4K | 0.01% | 951 |
|
2025
Q1 | $979K | Sell |
31,461
-6,914
| -18% | -$215K | 0.01% | 961 |
|
2024
Q4 | $979K | Sell |
38,375
-9,371
| -20% | -$239K | 0.01% | 983 |
|
2024
Q3 | $1.35M | Sell |
47,746
-625
| -1% | -$17.7K | 0.01% | 830 |
|
2024
Q2 | $1.28M | Sell |
48,371
-41,778
| -46% | -$1.1M | 0.02% | 756 |
|
2024
Q1 | $2.74M | Buy |
90,149
+19,834
| +28% | +$603K | 0.05% | 399 |
|
2023
Q4 | $1.98M | Buy |
70,315
+13,213
| +23% | +$371K | 0.05% | 358 |
|
2023
Q3 | $1.55M | Buy |
57,102
+504
| +0.9% | +$13.7K | 0.05% | 389 |
|
2023
Q2 | $1.74M | Buy |
56,598
+614
| +1% | +$18.9K | 0.05% | 362 |
|
2023
Q1 | $2.02M | Buy |
55,984
+4,468
| +9% | +$161K | 0.07% | 286 |
|
2022
Q4 | $2.04M | Buy |
51,516
+8,743
| +20% | +$346K | 0.08% | 275 |
|
2022
Q3 | $1.72M | Buy |
42,773
+1,603
| +4% | +$64.4K | 0.07% | 250 |
|
2022
Q2 | $1.73M | Buy |
41,170
+6,433
| +19% | +$270K | 0.06% | 255 |
|
2022
Q1 | $1.35M | Buy |
34,737
+13,689
| +65% | +$533K | 0.04% | 340 |
|
2021
Q4 | $839K | Sell |
21,048
-3,620
| -15% | -$144K | 0.03% | 457 |
|
2021
Q3 | $901K | Buy |
24,668
+18,708
| +314% | +$683K | 0.03% | 359 |
|
2021
Q2 | $244K | Buy |
+5,960
| New | +$244K | 0.01% | 639 |
|